First report of putative <i>Leishmania</i> RNA virus 2 (LRV2) in <i>Leishmania infantum</i> strains from canine and human visceral leishmaniasis cases in the southeast of Brazil

Carregando...
Imagem de Miniatura
Citações na Scopus
0
Tipo de produção
article
Data de publicação
2023
Título da Revista
ISSN da Revista
Título do Volume
Editora
FUNDACO OSWALDO CRUZ
Autores
REGO, Felipe Dutra
SILVA, Eduardo Sergio da
LOPES, Valeriana Valadares
TEIXEIRA-NETO, Rafael Goncalves
BELO, Vinicius Silva
JR, Antonio Augusto Fonseca
PEREIRA, Diego Andrade
PENA, Heber Paulino
Citação
MEMORIAS DO INSTITUTO OSWALDO CRUZ, v.118, article ID e230071, 8p, 2023
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
BACKGROUND Leishmania RNA virus 1 (LRV1) is commonly found in South American Leishmania parasites belonging to the subgenus Viannia, whereas Leishmania RNA virus 2 (LRV2) was previously thought to be restricted to the Old-World pathogens of the subgenus Leishmania. OBJECTIVES In this study, we investigated the presence of LRV2 in strains of Leishmania (L.) infantum, the causative agent of visceral leishmaniasis (VL), originating from different hosts, clinical forms, and geographical regions. METHODS A total of seventy-one isolates were screened for LRV2 using semi-nested reverse transcription-polymerase chain reaction (RT-PCR) targeting the RNA-dependent RNA polymerase (RdRp) gene. FINDINGS We detected LRV2 in two L. infantum isolates (CUR268 and HP-EMO) from canine and human cases, respectively. MAIN CONCLUSIONS To the best of our knowledge, this is the first detection of LRV2 in the New World.
Palavras-chave
Leishmania, Leishmania infantum, leishmaniasis, Leishmania RNA virus, Totiviridae
Referências
  1. Adaui V, 2016, J INFECT DIS, V213, P112, DOI 10.1093/infdis/jiv354
  2. Atayde VD, 2019, NAT MICROBIOL, V4, P714, DOI 10.1038/s41564-018-0352-y
  3. Brettmann EA, 2016, P NATL ACAD SCI USA, V113, P11998, DOI 10.1073/pnas.1615085113
  4. Bruschi F, 2018, The leishmaniases: Old neglected tropical diseases, V1
  5. Cantanhêde LM, 2021, GENES-BASEL, V12, DOI 10.3390/genes12050657
  6. Cantanhede LM, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004079
  7. de Carvalho RVH, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-13356-2
  8. Desjeux P, 2001, T ROY SOC TROP MED H, V95, P239, DOI 10.1016/S0035-9203(01)90223-8
  9. Eren RO, 2016, CELL HOST MICROBE, V20, P318, DOI 10.1016/j.chom.2016.08.001
  10. Garcia L, 2004, J CLIN MICROBIOL, V42, P2294, DOI 10.1128/JCM.42.5.2294-2297.2004
  11. Ginouves M, 2016, AM J TROP MED HYG, V94, P102, DOI 10.4269/ajtmh.15-0419
  12. Grybchuk D, 2020, VIRUSES-BASEL, V12, DOI 10.3390/v12020168
  13. Grybchuk D, 2018, MBIO, V9, DOI [10.1128/mBio.01932-18, 10.1128/mbio.01932-18]
  14. Gupta V, 2007, Indian J Med Microbiol, V25, P7
  15. Hajjaran H, 2016, ARCH VIROL, V161, P3385, DOI 10.1007/s00705-016-3044-z
  16. Hartley MA, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005852
  17. Hartley MA, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00099
  18. Ives A, 2011, SCIENCE, V331, P775, DOI 10.1126/science.1199326
  19. Kariyawasam R, 2017, J INFECT DIS, V216, P877, DOI 10.1093/infdis/jix416
  20. Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010
  21. Kleschenko Y, 2019, GENES-BASEL, V10, DOI 10.3390/genes10100830
  22. Kostygov AY, 2021, VIRUSES-BASEL, V13, DOI 10.3390/v13112305
  23. Kostygov AY, 2021, OPEN BIOL, V11, DOI 10.1098/rsob.200407
  24. Kuhlmann FM, 2017, P NATL ACAD SCI USA, V114, pE811, DOI 10.1073/pnas.1619114114
  25. Lafleur A, 2022, PLOS PATHOG, V18, DOI 10.1371/journal.ppat.1010910
  26. Macedo DH, 2016, MOL BIOCHEM PARASIT, V210, P50, DOI 10.1016/j.molbiopara.2016.08.005
  27. Mann S, 2021, CURR TROP MED REP, V8, P121, DOI 10.1007/s40475-021-00232-7
  28. Mendes AAV, 2023, MEM I OSWALDO CRUZ, V118, DOI 10.1590/0074-02760220220
  29. Minh BQ, 2020, MOL BIOL EVOL, V37, P1530, DOI 10.1093/molbev/msaa015
  30. Nalçaci M, 2019, T ROY SOC TROP MED H, V113, P410, DOI 10.1093/trstmh/trz023
  31. Ogg MM, 2003, AM J TROP MED HYG, V69, P309, DOI 10.4269/ajtmh.2003.69.309
  32. Olivier M, 2020, CURR OPIN IMMUNOL, V66, P108, DOI 10.1016/j.coi.2020.08.004
  33. PAHO-Pan American Health Organization, 2020, Leishmaniases. Epidemiological report of the Americas
  34. Paranaiba LF, 2018, PARASITOLOGY, V145, P1265, DOI 10.1017/S0031182017001810
  35. Pereira LDR, 2013, MEM I OSWALDO CRUZ, V108, P665, DOI 10.1590/0074-0276108052013021
  36. Robinson JI, 2018, J BIOL CHEM, V293, P6460, DOI [10.1074/jbc.ra117.001515, 10.1074/jbc.RA117.001515]
  37. Rossi M, 2017, P NATL ACAD SCI USA, V114, P4987, DOI 10.1073/pnas.1621447114
  38. Saberi R, 2020, INT J INFECT DIS, V101, P6, DOI 10.1016/j.ijid.2020.08.033
  39. Saberi R, 2019, TRANSBOUND EMERG DIS, V66, P2244, DOI 10.1111/tbed.13316
  40. Salinas G, 1996, AM J TROP MED HYG, V54, P425, DOI 10.4269/ajtmh.1996.54.425
  41. Saura A, 2022, MSPHERE, V7, DOI 10.1128/msphere.00335-22
  42. SCHEFFTER SM, 1995, VIROLOGY, V212, P84, DOI 10.1006/viro.1995.1456
  43. Tamura K, 2021, MOL BIOL EVOL, V38, P3022, DOI 10.1093/molbev/msab120
  44. WIDMER G, 1995, NUCLEIC ACIDS RES, V23, P2300, DOI 10.1093/nar/23.12.2300
  45. Yurchenko V, 2023, PARASITOLOGY, V150, P129, DOI 10.1017/S0031182022001640
  46. Zabala-Peñafiel A, 2022, MEM I OSWALDO CRUZ, V117, DOI 10.1590/0074-02760210107
  47. Zangger H, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002836